TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Operating Margin
- Operating margin · 12 months: Value 9.26%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.26% | Operating income / revenue. Period ending 2026-06-30. $1.60B ÷ $17.32B × 100 ≈ 9.26% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.60B USD | Operating Income (Loss) |
| Revenue | 17.32B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 8.23B USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.60B | $17.32B | $8.23B | (m) | (m) | 9.26% |
| 2026-03-31 | $2.29B | $17.35B | $8.32B | (m) | (m) | 13.20% |
| 2025-12-31 | $2.16B | $17.26B | $8.32B | (m) | (m) | 12.50% |
| 2025-09-30 | $1.83B | $16.78B | $8.37B | (m) | (m) | 10.90% |
| 2025-06-30 | $895.00M | $16.63B | $8.38B | (m) | (m) | 5.38% |
| 2025-03-31 | $434.00M | $16.62B | $8.45B | (m) | (m) | 2.61% |
| 2024-12-31 | $-303.00M | $16.54B | $8.48B | (m) | (m) | -1.83% |
| 2024-09-30 | $482.00M | $16.77B | $8.41B | (m) | (m) | 2.87% |
| 2024-06-30 | $877.00M | $16.29B | $8.23B | (m) | (m) | 5.38% |
| 2024-03-31 | $228.00M | $16.00B | $8.17B | (m) | (m) | 1.42% |
| 2023-12-31 | $433.00M | $15.85B | $8.20B | (m) | (m) | 2.73% |
| 2023-09-30 | $-1.14B | $15.27B | $8.27B | (m) | (m) | -7.49% |
| 2023-06-30 | $-1.08B | $15.02B | $8.20B | (m) | (m) | -7.20% |
| 2023-03-31 | $-1.38B | $14.93B | $8.11B | (m) | (m) | -9.27% |
| 2022-12-31 | $-2.10B | $14.93B | $7.95B | $98.00M | (m) | -14.06% |
| 2022-09-30 | $-1.17B | $15.14B | $7.89B | (m) | (m) | -7.70% |
| 2022-06-30 | $-961.00M | $15.43B | $8.06B | (m) | (m) | -6.23% |
| 2022-03-31 | $569.00M | $15.56B | $8.10B | (m) | (m) | 3.66% |
| 2021-12-31 | $1.72B | $15.88B | $8.28B | (m) | (m) | 10.81% |
| 2021-09-30 | $2.04B | $16.23B | $8.64B | (m) | (m) | 12.59% |
| 2021-06-30 | $-2.92B | $16.32B | $8.67B | (m) | (m) | -17.89% |
| 2021-03-31 | $-3.33B | $16.28B | $8.74B | (m) | (m) | -20.44% |
| 2020-12-31 | $-3.57B | $16.66B | $8.93B | (m) | (m) | -21.44% |
| 2020-09-30 | $-3.83B | $16.67B | $9.04B | (m) | (m) | -22.97% |
| 2020-06-30 | $431.00M | $16.79B | $9.18B | (m) | (m) | 2.57% |
| 2020-03-31 | $-386.00M | $17.09B | $9.35B | (m) | (m) | -2.26% |
| 2019-12-31 | $-443.00M | $16.89B | $9.35B | (m) | (m) | -2.62% |
| 2019-09-30 | $-3.75B | $17.45B | $9.91B | (m) | (m) | -21.51% |
| 2019-06-30 | $-3.66B | $17.72B | $10.02B | (m) | (m) | -20.64% |
| 2019-03-31 | $-3.03B | $18.08B | $10.25B | (m) | (m) | -16.74% |
| 2018-12-31 | $-1.64B | $18.85B | $10.56B | $114.00M | (m) | -8.68% |
| 2018-09-30 | $-11.49B | $19.69B | $10.78B | $54.00M | (m) | -58.35% |
| 2018-06-30 | $-11.13B | (m) | $11.24B | $229.00M | (m) | (m) |
| 2018-03-31 | $-16.85B | $21.80B | $11.47B | $229.00M | (m) | -77.31% |
| 2017-12-31 | $-17.48B | $22.39B | $11.56B | $175.00M | (m) | -78.11% |
| 2017-09-30 | $-4.60B | $23.42B | $11.74B | $335.00M | (m) | -19.66% |
| 2017-06-30 | $-4.22B | $23.37B | $11.54B | $412.00M | (m) | -18.04% |
| 2017-03-31 | $1.88B | $22.72B | $10.84B | $412.00M | (m) | 8.29% |
| 2016-12-31 | $2.15B | $21.90B | $10.04B | $422.00M | (m) | 9.83% |
| 2016-09-30 | $3.22B | $20.29B | $8.98B | $273.00M | (m) | 15.88% |
| 2016-06-30 | $3.47B | $19.55B | $8.27B | $21.00M | (m) | 17.73% |
| 2016-03-31 | $3.77B | $19.48B | $8.17B | $45.00M | (m) | 19.34% |
| 2015-12-31 | $3.35B | $19.65B | $8.30B | $35.00M | (m) | 17.06% |
| 2015-09-30 | $3.36B | $19.94B | $8.54B | $24.00M | (m) | 16.87% |
| 2015-06-30 | $3.46B | $20.17B | $8.74B | $24.00M | (m) | 17.18% |
| 2015-03-31 | $3.73B | $20.25B | $9.06B | (m) | (m) | 18.41% |
| 2014-12-31 | $3.95B | $20.27B | $9.22B | $0.00 | (m) | 19.49% |
| 2014-09-30 | $3.57B | $20.53B | $9.47B | (m) | (m) | 17.38% |
| 2014-06-30 | $3.26B | $20.54B | $9.65B | (m) | (m) | 15.87% |
| 2014-03-31 | $1.75B | $20.41B | $9.60B | (m) | (m) | 8.56% |
| 2013-12-31 | $1.65B | $20.31B | $9.61B | $5.00M | (m) | 8.12% |
| 2013-09-30 | $1.42B | $20.13B | $9.54B | (m) | (m) | 7.05% |
| 2013-06-30 | $558.00M | $20.05B | $9.48B | (m) | (m) | 2.78% |
| 2013-03-31 | $2.15B | $20.12B | $9.48B | (m) | (m) | 10.69% |
| 2012-12-31 | $2.21B | $20.32B | $9.66B | (m) | (m) | 10.85% |
| 2012-09-30 | $2.48B | $20.74B | $10.00B | (m) | (m) | 11.98% |
| 2012-06-30 | $3.58B | $20.12B | $9.72B | (m) | (m) | 17.80% |
| 2012-03-31 | $3.17B | $19.33B | $9.40B | (m) | (m) | 16.40% |
| 2011-12-31 | $3.11B | $18.31B | $8.80B | (m) | (m) | 16.98% |
| 2011-09-30 | $3.27B | $17.05B | $7.96B | (m) | (m) | 19.19% |
| 2011-06-30 | $3.43B | $16.96B | $7.64B | (m) | (m) | 20.20% |
| 2011-03-31 | $3.90B | $16.55B | $7.31B | (m) | (m) | 23.59% |
| 2010-12-31 | $3.87B | $16.12B | $7.06B | (m) | (m) | 24.01% |
| 2010-09-30 | $3.51B | $15.51B | $6.80B | (m) | (m) | 22.63% |
| 2010-06-30 | $3.07B | $14.80B | $6.64B | (m) | (m) | 20.76% |
| 2010-03-31 | $2.70B | $14.40B | $6.60B | (m) | (m) | 18.75% |
| 2009-12-31 | $2.40B | $13.90B | $6.53B | (m) | (m) | 17.30% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $1.15B | $11.09B | $5.12B | (m) | (m) | 10.33% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $2.40B | $9.41B | $4.53B | (m) | (m) | 25.46% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.